Jul 31, 2026 04:11PM
Apr 8, 2026 08:00AM
Mar 25, 2026 05:24AM
Mar 24, 2026 08:54AM
Mar 24, 2026 06:39AM
Dec 22, 2025 07:15AM
Nov 10, 2025 04:18AM Context Therapeutics (CNTX) Can Swiftly Take Licensed Assets into Clinics - Citizens
Nov 6, 2025 04:21PM
Oct 24, 2025 04:04PM
Oct 2, 2025 06:03AM
Sep 17, 2025 04:11PM
Jun 26, 2025 07:56AM
Jun 3, 2025 04:19AM
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 29, 2025 07:31AM
May 28, 2025 04:25AM
May 7, 2025 04:17PM
May 5, 2025 04:06PM
Apr 30, 2025 07:31AM
Apr 21, 2025 06:37AM
Mar 24, 2025 05:43AM Citizens JMP Reiterates Market Outperform Rating on Context Therapeutics (CNTX)
Jan 14, 2025 04:59PM
Jan 13, 2025 07:30AM
Jan 8, 2025 03:14AM
Nov 7, 2024 06:27AM
Sep 27, 2024 08:39AM
Sep 24, 2024 06:49AM
Sep 23, 2024 07:31AM BioAtla (BCAB) and Context Therapeutics (CNTX) Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362
Sep 16, 2024 07:40AM
Sep 9, 2024 07:52AM
Sep 4, 2024 07:31AM
Aug 8, 2024 06:38AM
Aug 1, 2024 07:31AM
Jul 11, 2024 10:30AM
Jul 10, 2024 07:30AM Context Therapeutics (CNTX) Acquires Phase 1-ready T cell Engager CT-95

439,051 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All